Clarithromycin and Daliresp drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Clarithromycin (clarithromycin) and Daliresp (roflumilast). Common drug interactions include dysphagia among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Clarithromycin and Daliresp. It is created by eHealthMe based on reports of 37 people who take the same drugs from the FDA, and is updated regularly.

What is Clarithromycin?

Clarithromycin has active ingredients of clarithromycin. It is often used in sinusitis. eHealthMe is studying from 45,044 Clarithromycin users. Check the latest studies of Clarithromycin.

What is Daliresp?

Daliresp has active ingredients of roflumilast. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 4,722 Daliresp users. Check the latest studies of Daliresp.



On Jul, 16, 2026

37 people who take Clarithromycin and Daliresp together, and have interactions are studied.

Clarithromycin and Daliresp drug interactions.

What are the common drug interactions of Clarithromycin and Daliresp, by gender? *:

female:

  1. Dysphagia (a condition in which swallowing is difficult or painful)
  2. Infusion site bruising
  3. Infusion site swelling
  4. Intestinal fistula
  5. Weight decreased
  6. Abscess (pus)
  7. Chest pain
  8. Headache (pain in head)
  9. Infusion related reaction
  10. Paraesthesia oral (sensation of tingling, tickling, prickling, pricking, or burning of a person's oral with no apparent long-term physical effect)

male:

  1. Chronic kidney disease
  2. Decreased appetite
  3. Nephrogenic anaemia (anaemia due to kidney disease)
  4. Renal failure (kidney dysfunction)

What are the common drug interactions of Clarithromycin and Daliresp, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  2. Interstitial lung disease

50-59:

  1. Chest discomfort
  2. Cough
  3. Drug ineffective

60+:

  1. Respiratory tract infection
  2. Chest discomfort
  3. Costochondritis (chest wall pain)
  4. Rash
  5. Allergy to animal
  6. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  7. Hip fracture
  8. Hypoaesthesia oral (reduced sense of touch or sensation in mouth)
  9. Infusion site discomfort
  10. Infusion site pain

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 20 people, 54.05%
  2. High Blood Cholesterol: 5 people, 13.51%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 13.51%
  4. Cardiac Disorder: 4 people, 10.81%
  5. Inflammation: 4 people, 10.81%
  6. Vitamin E Deficiency: 2 people, 5.41%
  7. Chest Pain: 2 people, 5.41%
  8. Cough: 2 people, 5.41%
  9. Depression: 2 people, 5.41%
  10. Diabetes: 2 people, 5.41%

* Approximation only. Some reports may have incomplete information.

Do you take Clarithromycin and Daliresp?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Clarithromycin and Daliresp:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Clarithromycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Daliresp:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Clarithromycin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Daliresp and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on clarithromycin and roflumilast (the active ingredients of Clarithromycin and Daliresp, respectively), and Clarithromycin and Daliresp (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: